Trial intelligence / Profile preview

PRP, Insulin, and Vitamin C for Atrophic Scars

NCT07901283Completed

Start
Mar 2025
Primary completion
Mar 2026
Countries
1
01

Overview

Randomised trial of platelet-rich plasma, human insulin and ascorbic acid in atrophic scar (3 arms). Primary endpoint: Clinical improvement. Started Mar 2025; status: completed.

02

Drugs

platelet-rich plasmahuman insulinascorbic acid
03

Conditions

atrophic scar

Beyond the preview

Go deeper on NCT07901283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07901283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call